Riskpilot← Back to searchSign inGet full accessBromma Djurklinik AB
ABActiveOrg 5566534268Ulvsundavägen 152Veterinary activities · NACE 7500Est. 20040 employees
Revenue 2025
SEK 2,6M
-9% vs 2024
EBITDA margin
-11.6%
-244% vs 2024
Equity ratio
49.4%
Financial strength
Net profit 2025
SEK 29K
-97% vs 2024
| Revenue | SEK 2,6M | -9% |
| EBITDA | SEK -302K | -244% |
| Net profit | SEK 29K | -97% |
| Total assets | SEK 1,4M | -23% |
| Equity | SEK 682K | -44% |
| Employees | 0 | — |
Legal name
Bromma Djurklinik AB
Org number
5566534268
Legal form
Aktiebolag
NACE code
7500 · Veterinary activities
Founded
2 januari 2004
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Badjie, Buba
Company purpose
Bolaget skall bedriva veterinärverksamhet samt därmed närliggande verksamheter.
Address
Ulvsundavägen 152
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 017 | 3 482 | 3 331 | 2 881 | 2 613 |
| Staff expenses | — | — | −1 754 | −1 574 | −1 806 |
| EBITDA | 431 | 256 | 412 | 209 | −302 |
| Depreciation & amort. | −30 | −32 | −36 | −29 | −34 |
| EBIT | 401 | 224 | 376 | 180 | −336 |
| Net financials | −10 | −5 | −3 | 6 | 8 |
| Profit before tax | 218 | −5 | 373 | 1 089 | 38 |
| Tax | −32 | −0 | −79 | −230 | −9 |
| Net profit | 186 | −5 | 294 | 860 | 29 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 479 | 2 540 | 2 712 | 1 805 | 1 381 |
| Equity | 1 068 | 1 063 | 1 357 | 1 217 | 682 |
| Long-term debt | 92 | 0 | — | — | — |
| Short-term debt | 1 319 | 1 477 | 1 354 | 588 | 699 |
| Total debt | 1 411 | 1 477 | 1 354 | 588 | 699 |
EBITDA margin
-11.6%
This company
15.8%
Market median
-173% vs market
20212025
Equity ratio
49.4%
This company
38.2%
Market median
+29% vs market
20212025
Return on equity
4.2%
This company
18.4%
Market median
-77% vs market
20212025
Net profit margin
1.1%
This company
8.1%
Market median
-86% vs market
20212025
Asset turnover
1.89×
This company
1.12×
Market median
+69% vs market
20212025
Debt / equity
1.02×
This company
0.62×
Market median
-65% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
EL Audit | Audit | 2022 |
BB Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Bromma Djurklinik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erika Larsdotter Hed | Audit | 0 companies |
| Buba Badjie | Chief Executive Officer | 0 companies |
| Coumba Jeanne Fall | Deputy Board Member | 0 companies |